The Statin Data Peter Attia Deleted

Introduction to the Omitted Statin Graph00:00

Dr. Peter Attia is hiding a graph showing that statins, specifically atorvastatin, the most profitable drug in history grossing over $150 billion, slashes GLP-1 levels in a human controlled trial. In a response letter, Peter attempted to discredit this study but completely omitted its central graphic while cherry-picking other panels from the same figure showing total cholesterol and LDL reductions. Omitting the most important result is curation, not nuance or accuracy.

Clarifying Intent and Approach00:30

This is not a personal attack, not about personalities, data, and logic. Not manufacturing controversy. Responding directly and transparently to arguments Peter made publicly in response to my work. Goal is thoughtful, substantive content to build a healthier intellectual ecosystem around science, medicine, and social media. Abbreviated version; full letter linked below.

Context of Peter's Responses01:32

Peter responding to my work, a repeated pattern. Most recently, devoted newsletter to a paper published 2 years ago described as recent, after I covered it extensively (threads, IG posts, newsletters, videos) and tagged him. Paper jumped to top of Cell Metabolism's most read list post-coverage. Less than 2 weeks later, his response appeared; others noted the connection publicly.

Prior Instance03:01

Shortly before, Peter invoked lean mass hyper-responder phenotype, area of active debate where I and colleagues are spearheading research. Collaborated with Peter's past head of research Bob Kaplan; offered direct collaboration with Peter in Journal of Clinical Lipidology editorial, which he declined citing lack of credibility.